AU4082300A - Hiv tat peptides and multiple peptide conjugate system - Google Patents

Hiv tat peptides and multiple peptide conjugate system

Info

Publication number
AU4082300A
AU4082300A AU40823/00A AU4082300A AU4082300A AU 4082300 A AU4082300 A AU 4082300A AU 40823/00 A AU40823/00 A AU 40823/00A AU 4082300 A AU4082300 A AU 4082300A AU 4082300 A AU4082300 A AU 4082300A
Authority
AU
Australia
Prior art keywords
peptide conjugate
hiv tat
multiple peptide
conjugate system
tat peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU40823/00A
Inventor
Robert A. Boykins
Subhash Dhawan
Manju B. Joshi
Hira L. Nakhasi
Chiang Syin
Kenneth M. Yamada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU4082300A publication Critical patent/AU4082300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU40823/00A 1999-06-21 2000-04-12 Hiv tat peptides and multiple peptide conjugate system Abandoned AU4082300A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US33831899A 1999-06-21 1999-06-21
US09/338318 1999-06-21
US17174299P 1999-12-22 1999-12-22
US60/171742 1999-12-22
PCT/US2000/010119 WO2000078969A1 (en) 1999-06-21 2000-04-12 Hiv tat peptides and multiple peptide conjugate system

Publications (1)

Publication Number Publication Date
AU4082300A true AU4082300A (en) 2001-01-09

Family

ID=26867382

Family Applications (1)

Application Number Title Priority Date Filing Date
AU40823/00A Abandoned AU4082300A (en) 1999-06-21 2000-04-12 Hiv tat peptides and multiple peptide conjugate system

Country Status (2)

Country Link
AU (1) AU4082300A (en)
WO (1) WO2000078969A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO314587B1 (en) * 2000-09-04 2003-04-14 Bionor Immuno As HIV regulatory and auxiliary peptides, antigens, vaccine preparations, immunoassay test kits and a method for detecting antibodies induced by HIV
EP1279404A1 (en) 2001-07-26 2003-01-29 Istituto Superiore di Sanità Use of HIV-1 tat, fragments or derivatives thereof, to target or to activate antigen-presenting cells, to deliver cargo molecules for vaccination or to treat other diseases
US20060104988A1 (en) * 2002-12-18 2006-05-18 Pauza C D Vaccines against hiv-1 tat protein to generate neutralizing antibodies
US20050208482A1 (en) 2004-03-16 2005-09-22 Cohen David I Tat-based immunomodulatory compositions and methods for their discovery and use
WO2008021295A2 (en) * 2006-08-14 2008-02-21 Thymon, L.L.C. Compositions and methods for the treatment and prophylaxis of multiple strains and subtypes of hiv-1
EP2274427A4 (en) * 2008-05-14 2012-03-28 Jncasr Bangalore Tat dna sequences, gene constructs, vaccine and processes thereof
CA2755897C (en) 2009-03-23 2020-01-28 Nanirx, Inc. Treatment of cancers with immunostimulatory hiv tat derivative polypeptides
WO2015051245A1 (en) 2013-10-04 2015-04-09 Pin Pharma, Inc. Immunostimulatory hiv tat derivative polypeptides for use in cancer treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69333111T2 (en) * 1992-04-24 2004-04-22 Institut for Human Genetics and Biochemistry NATURAL HUMAN IGM ANTIBODIES
WO1994015634A1 (en) * 1992-12-30 1994-07-21 Matthias Rath Tat and rev oligopeptides in hiv treatment
US5891994A (en) * 1997-07-11 1999-04-06 Thymon L.L.C. Methods and compositions for impairing multiplication of HIV-1
US6610833B1 (en) * 1997-11-24 2003-08-26 The Institute For Human Genetics And Biochemistry Monoclonal human natural antibodies
IT1297090B1 (en) * 1997-12-01 1999-08-03 Barbara Ensoli TAT OF HIV-1 OR ITS DERIVATIVES, ALONE OR IN COMBINATION, FOR VACCINAL, PROPHYLACTIC AND THERAPEUTIC PURPOSES, AGAINST AIDS, CANCERS AND

Also Published As

Publication number Publication date
WO2000078969A1 (en) 2000-12-28

Similar Documents

Publication Publication Date Title
AU7358700A (en) Dolastatin peptides
AU5440901A (en) Cosmetic and/or pharmaceutical preparations
AU5335698A (en) Pharmaceutical formulations with delayed drug release
AU1951201A (en) Peptide antigens
AU6058500A (en) Fusion protein and uses thereof
AU2001221978A1 (en) Position and orientation detection system
AU6173900A (en) Peptide transport
AU6086398A (en) Image-directed active range finding system
AU2003201281A1 (en) Antimicrobial peptides and derived metapeptides
AU4082300A (en) Hiv tat peptides and multiple peptide conjugate system
AU4776800A (en) Acetylcholinesterase-derived peptides and uses thereof
AUPO026596A0 (en) Viral peptide
AU2438400A (en) Cosmetic and/or pharmaceutical preparations
AU4293800A (en) Cosmetic and/or pharmaceutical preparations
AU3594300A (en) Product registration system and a hangtag usable therewith
AU7308200A (en) Novel hev antigenic peptide and methods
AU2660400A (en) Rantes-derived peptides with anti-hiv activity
GB9918155D0 (en) Proteins and peptides
AU6179600A (en) Peptides and pharmaceutical compositions comprising same
AU2001266347A1 (en) Enteric preparations containing physiologically active peptides
AU3552797A (en) Vaccine preparations
AU1800100A (en) Medicinal preparations
AU3473800A (en) Conotoxin peptides
AU1821300A (en) Peptides having anti-cancer and anti-inflammatory activity
AU6301698A (en) Anti-hiv peptides and proteins

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase